We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study

By MedImaging International staff writers
Posted on 23 Oct 2023
Print article
Image: New U.S. FDA-approved AI medical imaging products are expected to increase five-fold by 2035 (Photo courtesy of ACR DSI)
Image: New U.S. FDA-approved AI medical imaging products are expected to increase five-fold by 2035 (Photo courtesy of ACR DSI)

A just-released study has projected a five-fold increase in new artificial intelligence (AI) medical imaging products approved by the U.S. Food and Drug Administration (FDA) by 2035. The projection of the number of new FDA-approved products is based on the historical relationship between the number of new products and AI venture capital funding in the past.

The Harvey L. Neiman Health Policy Institute (Reston, VA, USA) and American College of Radiology Data Science Institute (Reston, VA, USA) study reveals that annual funding for AI rose from USD 2 billion in 2013 to USD 13 billion in 2022. At the current pace, it takes roughly six years from the time of funding to receiving FDA approval. The study anticipates 147 new AI products to hit the market in 2028, taking into account the USD 13 billion funding received in 2022. If the rate of funding continues to witness a similar linear trend as earlier, the study predicts that the funding will reach USD 30.8 billion in 2029, resulting in a five-fold increase in FDA-approved products by 2035.

“Given the relationship between funding and new AI products, we project there will be 350 new AI products in 2035 corresponding to the 2029 funding level given the lag between funding and approved products. This is a five-fold increase from 69 in 2022,” said Eric Christensen, PhD, Research Director at the Neiman Health Policy Institute.

“Artificial intelligence has grown rapidly and is already changing the way healthcare professionals work,” said Christopher Treml, DSI director of operations. “Based on this research, we expect that growth to continue accelerating over the next decade and change the field in new and exciting ways as AI products are developed and integrated into practice.”

Related Links:
Harvey L. Neiman HPI

Gold Supplier
Ultrasound System
Gold Supplier
Conductive Gel
Ultrasonic Diagnostic System
Silver Supplier
Bucky Protector
Bucky Protector

Print article



view channel
Image: Intelligent NR provides high-quality diagnostic images containing significantly less grainy noise (Photo courtesy of Canon)

AI-Driven DR System Produces Higher Quality Images While Limiting Radiation Doses in Pediatric Patients

Ionizing radiation is a fundamental element in producing diagnostic X-rays, yet it's widely acknowledged for its cancer risk potential. Digital projection radiography, a vital imaging modality, accounts... Read more


view channel
Image: The researchers are using MRI-guided radiation therapy that pairs daily MRIs with radiation treatment (Photo courtesy of Sylvester)

AI Technique Automatically Traces Tumors in Large MRI Datasets to Guide Real-time Glioblastoma Treatment

Treating glioblastoma, a prevalent and aggressive brain cancer, involves the use of radiation therapy guided by CT imaging. While this method is effective in targeting radiation, it doesn't provide real-time... Read more


view channel
Image: The new ultrasound patch can measure how full the bladder is (Photo courtesy of MIT)

Ultrasound Patch Designed to Monitor Bladder and Kidney Health Could Enable Earlier Cancer Diagnosis

Bladder dysfunction and related health issues affect millions worldwide. Monitoring bladder volume is crucial for assessing kidney health. Traditionally, this requires a visit to a medical facility and... Read more

Nuclear Medicine

view channel
Image: A novel PET radiotracer facilitates early, noninvasive detection of IBD (Photo courtesy of Karmanos)

New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is an inflammatory condition of the gastrointestinal tract affecting roughly seven million individuals globally.... Read more

General/Advanced Imaging

view channel
Image: Artificial intelligence predicts therapy responses for ovarian cancer (Photo courtesy of 123RF)

AI Model Combines Blood Test and CT Scan Analysis to Predict Therapy Responses in Ovarian Cancer Patients

Ovarian cancer annually impacts thousands of women, with many diagnoses occurring at advanced stages due to subtle early symptoms. High-grade serous ovarian carcinoma, which accounts for 70-80% of ovarian... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.